Interleukin-6 in Spinal Cord Injury: Could Immunomodulation Replace Immunosuppression in the Management of Acute Traumatic Spinal Cord Injuries?
Journal of Neurological Surgery Part A: Central European Neurosurgery · 01.11.2024 · 85 (06) · 602-609
DOI: 10.1055/a-2111-5698 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurological Surgery Part A: Central European Neurosurgery, erschienen am 01.11.2024. Verfasst von Hank Shipman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Interleukin-6. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Traumatic spinal cord injuries (SCI) result in devastating impairment to an individual's functional ability. The pathophysiology of SCI is related to primary injury but further propagated by secondary reactions to injury, such as inflammation and oxidation. The inflammatory and oxidative cascades ultimately cause demyelination and Wallerian degeneration. Currently, no treatments are available to treat primary or secondary injury in SCI, but some studies have shown promising results by lessening secondary mechanisms of injury. Interleukins (ILs) have been described as key players in the inflammation cascade after neuronal injury; however, their role and possible inhibition in the context of acute traumatic SCIs have not been widely studied. Here, we review the relationship between SCI and IL-6 concentrations in the CSF and serum of individuals after traumatic SCIs. Furthermore, we explore the dual IL-6 signaling pathways and their relevance for future IL-6 targeted therapies in SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States.
- University of South Florida Morsani College of Medicine, Tampa, Florida, United States.
- Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.
- Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, United States.
- Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, Florida, United States.
ORCID-Profile: Davide M Croci, Erica F Bisson
Zitieren
APA
Shipman, H., Monsour, M., Foley, M. M., Marbacher, S., Croci, D. M., & Bisson, E. F. (2024). Interleukin-6 in Spinal Cord Injury: Could Immunomodulation Replace Immunosuppression in the Management of Acute Traumatic Spinal Cord Injuries?. Journal of Neurological Surgery Part A: Central European Neurosurgery, 85(06), 602-609. https://doi.org/10.1055/a-2111-5698
Vancouver
Shipman H, Monsour M, Foley MM, Marbacher S, Croci DM, Bisson EF. Interleukin-6 in Spinal Cord Injury: Could Immunomodulation Replace Immunosuppression in the Management of Acute Traumatic Spinal Cord Injuries?. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2024;85(06):602-609. doi:10.1055/a-2111-5698
BibTeX
@article{Shipman2024,
author = {Shipman, Hank and Monsour, Molly and Foley, Madeline M and Marbacher, Serge and Croci, Davide M and Bisson, Erica F},
title = {Interleukin-6 in Spinal Cord Injury: Could Immunomodulation Replace Immunosuppression in the Management of Acute Traumatic Spinal Cord Injuries?},
journal = {Journal of Neurological Surgery Part A: Central European Neurosurgery},
year = {2024},
volume = {85},
number = {06},
pages = {602--609},
doi = {10.1055/a-2111-5698}
}
EUVIMED